Table Q

Depression/OCD/PD/PTSD studies – Olanzapine with Fluoxetine Comapred to Fluoxetine

Adverse Events# of studiesFluoxetineOlanzapine + FluoxetinePooled OR95% CI
# adverse eventssample size# adverse eventssample size
Neuro1014115+Inf(0.02, +Inf)
Neuro/Movement Disorder1014015NCNC
Neuro/Movement Disorder/Akathisia15145150.90(0.15, 5.44)
Neuro/Movement Disorder/Tardive Dyskinesia1014015NCNC
Neuro/Sedation13147153.08(0.50, 24.41)
Psychiatric/Suicide Attempt11140150.00(0.00, 36.40)

NC = Not Calculated

From: Appendix E, Adverse Event Analysis

Cover of Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics
Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics [Internet].
Comparative Effectiveness Reviews, No. 6.
Shekelle P, Maglione M, Bagley S, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.